Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia …
C Dagli-Hernandez, GM Ferreira… - Pharmacogenetics …, 2024 - journals.lww.com
Objectives This study explored the association of deleterious variants in pharmacodynamics
(PD) genes with statin response and adverse effects in patients with familial …
(PD) genes with statin response and adverse effects in patients with familial …